SAVO Cannabis announced the development of a genetics focused cannabis cultivation facility funded by Atlanta-based Brightsmith Capital Partners.
The facility will focus on developing genetics and cultivation methods to grow flower with specifically designed terpene and cannabinoid profiles with a goal to provide product with targeted effects.
To achieve more control over plant development, they’ve chosen programmable spectrum LEDs from Revolution Micro for Phase II. These LEDs will allow them to use plants’ natural responses to different colors of light to influence the chemical composition of the crop. Terpenes, which can be triggered by blue light, have been shown to have hundreds of cancer fighting and wellness enhancing properties. SAVO will craft designer strains that target specific mental and physical responses to help people live healthier, happier lives.
SAVO is anticipating the facility to have its first harvest in June of 2023, and intends on breaking ground on a second building in Oklahoma in Q4.